Pegylated Interferon | List of Frontiers open access articles

Case Report

Published on 15 Feb 2023

Case report: Unusual viral evolutions following antiviral therapies in a patient with concurrent hepatitis B virus and hepatitis C virus infection

in Hepatology

Yi-Tse Su
Ming-Ling Chang
Yun-Fan Liaw

Frontiers in Medicine

doi 10.3389/fmed.2023.1136111

2,148 views
2 citations

Case Report

Published on 12 Dec 2024

Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report

in Blood Cancer

Selene Grano
Valentina Bonuomo
Diana Carli
Veronica Peri
Loredana Farinasso
Ugo Ramenghi
Daniela Cilloni
Carmen Fava

Frontiers in Hematology

doi 10.3389/frhem.2024.1508463

1,512 views

Case Report

Published on 11 Oct 2021

Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review

in Hematologic Malignancies

Yingxin Sun
Yifeng Cai
Jia Chen
Jiannong Cen
Mingqing Zhu
Jinlan Pan
Depei Wu
Aining Sun
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.753842

5,515 views
5 citations

Original Research

Published on 21 Dec 2021

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World

in Hematologic Malignancies

Yingxin Sun
Yifeng Cai
Jiannong Cen
Mingqing Zhu
Jinlan Pan
Qian Wang
Depei Wu
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.797825

10,485 views
7 citations

Original Research

Published on 11 Dec 2025

Safety evaluation and toxicokinetics of repeated inhalation exposure to pegylated interferon α-2b

in Drug Metabolism and Transport

Cuifang Ji
Xunlian Ji
Huan Li
Qinfang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1689087

762 views

Case Report

Published on 26 Sep 2024

Case report: Tenosynovial giant cell tumor

in Cancer Molecular Targets and Therapeutics

Anke Fähnrich
Zhala Gasimova
Yamil Maluje
Fabian Ott
Helen Sievert
Stephanie Fliedner
Niklas Reimer
Axel Künstner
Niklas Gebauer
Maxim Kebenko

Frontiers in Oncology

doi 10.3389/fonc.2024.1445427

4,909 views
2 citations

Systematic Review

Published on 05 Jul 2024

Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B

in Pharmacology of Infectious Diseases

Na Wei
Bin Zheng
Hongfu Cai
Na Li
Jing Yang
Maobai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403805

3,486 views
5 citations

Original Research

Published on 05 Sep 2025

Short-term pegylated interferon alpha in chronic HBV patients with ultra-low HBsAg: a retrospective study

in Clinical Infectious Diseases

Huimin Liu
Hongmei Gong
Zhaoxia Tan
Yanyan Wu
Lijian Ran
Qing Mao
Guohong Deng
Li Jiang
Jie Xia

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1582997

2,721 views

Original Research

Published on 22 Apr 2022

Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers

in Viral Immunology

Hong Li
Xiao Lin
Lili Liu
Ling Qin
Yanhong Zheng
Xiaohui Liu
Xinhuan Wei
Shan Liang
Yali Liu
Jing Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.864354

3,097 views
5 citations

Original Research

Published on 05 Jan 2023

Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon

in Viral Immunology

Peipei Wang
Zhishuo Mo
Ying Zhang
Chunxia Guo
Trevor Kudzai Chikede
Dabiao Chen
Ziying Lei
Zhiliang Gao
Qian Zhang
Qiaoxia Tong

Frontiers in Immunology

doi 10.3389/fimmu.2022.1104329

4,034 views
7 citations

Original Research

Published on 04 Dec 2023

Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B

in Viral Immunology

Liang Huang
Hong Zhang
Xintong Kang
Zhu Chen
Lin Wang
Yilan Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1282922

3,414 views
12 citations

Original Research

Published on 23 Dec 2022

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon

in Viral Immunology

Hong Li
Shan Liang
Lili Liu
Daqiong Zhou
Yali Liu
Yang Zhang
Xinyue Chen
Jing Zhang
Zhenhuan Cao

Frontiers in Immunology

doi 10.3389/fimmu.2022.1091786

7,557 views
10 citations

Systematic Review

Published on 04 Nov 2021

Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis

in Viral Immunology

Aixin Song
Xiao Lin
Junfeng Lu
Shan Ren
Zhenhuan Cao
Sujun Zheng
Zhongjie Hu
Hong Li
Chengli Shen
Xinyue Chen

Frontiers in Immunology

doi 10.3389/fimmu.2021.779347

8,729 views
43 citations

Case Report

Published on 27 Sep 2023

Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome

in Atherosclerosis and Vascular Medicine

Nathan Torcida
Giulia Casalino
Antoine Bondue
Lise Jodaitis
Frederic Vanden Eynden
Florence Roufosse

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1256862

3,327 views
4 citations

Original Research

Published on 14 May 2025

Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

in Hematologic Malignancies

Long Chang
Wen-Xin Li
Hao Cai
Jian Li
Ming-Hui Duan

Frontiers in Oncology

doi 10.3389/fonc.2025.1586839

3,711 views
1 citation

Original Research

Published on 25 Oct 2019

SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors α

in Experimental Pharmacology and Drug Discovery

Hui Jiang
Sheng-Tao Cheng
Ji-Hua Ren
Fang Ren
Hai-Bo Yu
Qing Wang
Ai-Long Huang
Juan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01270

7,100 views
29 citations

Articles

Case report: Unusual viral evolutions following antiviral therapies in a patient with concurrent hepatitis B virus and hepatitis C virus infection

Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report

Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World

Safety evaluation and toxicokinetics of repeated inhalation exposure to pegylated interferon α-2b

Case report: Tenosynovial giant cell tumor

Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B

Short-term pegylated interferon alpha in chronic HBV patients with ultra-low HBsAg: a retrospective study

Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers

Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon

Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon

Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis

Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome

Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors α